Izumiya Yasuhiro, Takashio Seiji, Oda Seitaro, Yamashita Yasuyuki, Tsujita Kenichi
Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
J Cardiol. 2018 Feb;71(2):135-143. doi: 10.1016/j.jjcc.2017.10.003. Epub 2017 Nov 5.
Cardiac amyloidosis (CA) has been believed to be a rare disease for a long time, but recent sophisticated diagnostic modalities demonstrate that a considerable number of CA patients are hidden among those diagnosed with heart failure. Prognosis of CA was poor, but recent developments in therapeutic interventions have improved survival in these patients. Therefore, early detection and precise diagnosis is clinically important. In this review article, we overview recent progress in diagnosis and treatment for CA.
长期以来，心脏淀粉样变性（CA）一直被认为是一种罕见疾病，但最近先进的诊断方法表明，相当数量的CA患者隐藏在那些被诊断为心力衰竭的患者之中。CA的预后很差，但最近治疗干预措施的进展提高了这些患者的生存率。因此，早期检测和精确诊断在临床上具有重要意义。在这篇综述文章中，我们概述了CA诊断和治疗的最新进展。
